Using proteomic and genomic technologies aided by bioanalysis, several EMT biomarkers were identified in CRC samples (e.g., BGN, MMP1, LGALS1, SERPINB5, and TM4SF4) and appended to the pathway of TGFβ/Snail triggered with TNFα/NFκB. The authors point out that poor prognosis is associated with these biomarkers that are reported as being involved in EMT process [61]. Here, NFKB1 is linked to colorectal carcinoma.